Search Results

that cancer treatments pose to fertility, and that they refer interested patients for appropriate fertility preservation. All patients of reproductive age who will receive therapy that is potentially gonadotoxic are considered candidates for fertility

in women of child-bearing age with breast cancer Outline both the established and emerging techniques for fertility preservation Review the barriers in fertility preservation and available data on the safety of pregnancy in breast cancer survivors

that may preserve the ability to have biological children in the future. Fertility Preservation Options Although the physiologic impact on the patient's fertility may be inevitable, the practical outcome—the ability to later have biological

treatment-related risk of infertility with patients of reproductive age to aid them with fertility preservation (FP) decisions as early as possible. 8 – 10 Additionally, clinicians must refer those interested in having children to preservation specialists

making decisions about fertility preservation. 4 The American Society for Reproductive Medicine (ASRM), 5 ASCO, 6 , 7 and NCCN 8 have each established national guidelines to enhance provider adherence and facilitate patient and provider discussions

of treatment-associated infertility and methods available for fertility preservation prior to treatment initiation. The discussion should be documented in the medical record system. Despite the emphasis on guidelines, fertility preservation is one of

developing infertility ( http://www.fertilehope.org/tool-bar/risk-calculator.cfm ). Fertility Preservation Fertility preservation is an issue of crucial importance in AYA patients with cancer and should be an essential part in the management of their

fertility preservation, and genetic and familial risk assessment (within 2 months after the start of therapy). Age-Appropriate Care: Pediatric Versus Adult Cancer Centers AYA patients with cancer can be treated at either pediatric or adult cancer

Increasing interest has recently been shown in quality-of-life issues for cancer survivors, including fertility preservation (FP). 1 - 12 Following the publication of the American Society of Reproductive Medicine’s guidelines on FP, 13 in 2006

addition to presence of providers with any amount of clinical effort (full-time equivalent [FTE] >0.1) dedicated solely to AYAO patients. The third section more specifically addressed aspects of AYAO care, including fertility preservation, sexual health